# Novo Biosciences, Inc. — Form D

Novo Biosciences, Inc. of Lamoine, ME, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-09. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-06-09
- Form: D
- Accession: 0001415889-20-001530
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $4.0M
- Minimum investment: $4.0M
- Investors: 1
- Date of first sale: 2020-05-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-368583

## Issuer

- Name: Novo Biosciences, Inc.
- CIK: 0001648277
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 22 Partridge Cove Road, Lamoine, ME, 04605
- Phone: (202) 669 0208

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Kevin Strange | Director | Lamoine, ME |
| Viravuth Yin | Director | Trenton, ME |
| Kevin Strange | Executive Officer | Lamoine, ME |
| Viravuth Yin | Executive Officer | Trenton, ME |
| Denise Barbut | Director | Philadelphia, PA |
| Daniel Coit | Director | Bar Harbor, ME |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2015-07-16](https://search.stillhousedata.com/formd/0001648277-15-000001) | D | $1.0M | $75K |

## More

- [CIK 1648277 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1648277&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001415889-20-001530.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.